In line with previous reports, we found no difference in plasma apoE levels between the diagnostic groups in either racial/ethnic group [10, 13], confirming that plasma apoE levels per se are not suitable as an AD diagnostic biomarker. This evidence concerns the gene APOE and Alzheimer disease.